Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
UPPSALA, Sweden, June 29 /PRNewswire/ --
- Financing Led by SLS Invest Will Fund Gyros to Profitability
Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein…